Nxera Pharma To Receive $8.6 Million Milestone Payment From Centessa Pharmaceuticals Following Late-Stage Development Progress
03/09/2026 07:32
BRIEF-Nxera Pharma Co., Ltd.- Nxera Pharma To Receive $8.6 Million Milestone Payment From Centessa Pharmaceuticals Following Late-Stage Development Progress Sept 3 (Reuters) - Nxera Pharma Co., Ltd. 4565.T:
NXERA PHARMA CO., LTD.: NXERA PHARMA TO RECEIVE $8.6 MILLION MILESTONE PAYMENT FROM CENTESSA PHARMACEUTICALS FOLLOWING LATE-STAGE DEVELOPMENT PROGRESS
NXERA PHARMA CO., LTD.: MILESTONE PAYMENT WILL BE RECOGNIZED AS REVENUE IN Q3 OF fiSCAL YEAR ENDING DECEMBER 31, 2026
Source text: ID:nTSuc81af0
Further company coverage: 4565.T
(Reporting by Tokyo Newsroom)
((+81345201189;))
Recent news on Nxera Pharma
See all newsNxera Pharma Submits Marketing Authorization Application For Vamorolone In South Korea For Treatment Of Duchenne Muscular Dystrophy
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Brief: Nxera Pharma - Entered Into Exclusive License, Supply And Commercialization Agreement With Synmosa For Quviviq Across Eight Asia-Pacific Markets
Brief: Nxera Announces Successful Resolution Of Minig Patent Infringement Action
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up